Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (690) 690
Book Review (395) 395
Patent (336) 336
Publication (152) 152
Newspaper Article (146) 146
Magazine Article (99) 99
Book / eBook (38) 38
Conference Proceeding (25) 25
Dissertation (24) 24
Book Chapter (23) 23
Trade Publication Article (16) 16
Reference (10) 10
Government Document (3) 3
Report (3) 3
Video Recording (3) 3
Web Resource (3) 3
Data Set (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
book reviews (298) 298
books (270) 270
index medicus (233) 233
humans (214) 214
physics (205) 205
nonfiction (183) 183
calculating (180) 180
computing (180) 180
counting (180) 180
electric digital data processing (164) 164
animals (146) 146
hiv-1 - immunology (114) 114
electricity (109) 109
electric communication technique (105) 105
virology (103) 103
transmission of digital information, e.g. telegraphiccommunication (102) 102
article (100) 100
immunology (100) 100
antibodies, neutralizing - immunology (94) 94
viruses (86) 86
hiv (84) 84
hiv antibodies - immunology (78) 78
novels (76) 76
female (73) 73
research (73) 73
human necessities (72) 72
vaccines (70) 70
antibodies (69) 69
hiv infections - immunology (69) 69
human immunodeficiency virus--hiv (69) 69
microbiology (64) 64
male (61) 61
performing operations (61) 61
transporting (61) 61
infection (56) 56
neutralization tests (56) 56
mice (52) 52
virus diseases (52) 52
immunodeficiency-virus type-1 (50) 50
multidisciplinary sciences (50) 50
aids vaccines - immunology (49) 49
hiv-1 - genetics (49) 49
infectious diseases (49) 49
hiv envelope protein gp120 - immunology (46) 46
neutralizing antibodies (46) 46
hygiene (45) 45
immunoglobulins (43) 43
medical or veterinary science (43) 43
peptides (43) 43
binding sites (41) 41
cell biology (41) 41
vaccine (41) 41
proteins (40) 40
analysis (39) 39
biographies (39) 39
vaccines and antiviral agents (39) 39
chemistry (38) 38
hiv infections - virology (38) 38
immunization (38) 38
monoclonal antibodies (38) 38
monoclonal-antibodies (38) 38
health aspects (37) 37
organic chemistry (37) 37
biology (36) 36
infections (36) 36
metallurgy (36) 36
molecular sequence data (36) 36
biochemistry & molecular biology (35) 35
env gene products, human immunodeficiency virus - immunology (35) 35
fixed constructions (35) 35
hiv-1 (35) 35
macaca mulatta (35) 35
biochemistry (34) 34
history (34) 34
preparations for medical, dental, or toilet purposes (34) 34
data processing systems or methods, specially adapted foradministrative, commercial, financial, managerial, supervisoryor forecasting purposes (32) 32
hiv antibodies - blood (32) 32
human monoclonal-antibodies (32) 32
human-immunodeficiency-virus (32) 32
mutation (32) 32
systems or methods specially adapted for administrative,commercial, financial, managerial, supervisory or forecastingpurposes, not otherwise provided for (32) 32
antibodies, monoclonal - immunology (31) 31
bottles, jars or similar containers (31) 31
dispensing, delivering or transferring liquids, not otherwiseprovided for (31) 31
liquid handling (31) 31
opening, closing (31) 31
adult (30) 30
aids vaccines (30) 30
amino acid sequence (30) 30
potent (30) 30
antigens (29) 29
broadly neutralizing antibodies (29) 29
hiv infection (29) 29
prevention (29) 29
viral antibodies (29) 29
writers (29) 29
aids (28) 28
medicine, research & experimental (28) 28
physiological aspects (28) 28
water supply (28) 28
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (14) 14
UTL at Downsview - May be requested (6) 6
Online Resources - Online (5) 5
UofT at Mississauga - Stacks (4) 4
UofT at Scarborough - Stacks (4) 4
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Gerstein Science - Stacks (3) 3
Music - Stacks (3) 3
Trinity College (John W Graham) - Storage (3) 3
Media Commons - Audio Visual (2) 2
Pontifical Inst. Mediaeval Studies - Library use only (2) 2
St. Michael's College (John M. Kelly) - 2nd Floor (2) 2
Victoria University E.J. Pratt - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
East Asian (Cheng Yu Tung) - Reference (1) 1
Music - Library use only (1) 1
Music - Protected Material (1) 1
Robarts - Reference (1) 1
Royal Ontario Museum - Rare Book (1) 1
St. Augustine's Seminary - Stacks (1) 1
Trinity College (John W Graham) - Reference (1) 1
Trinity College (John W Graham) - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1734) 1734
French (100) 100
German (53) 53
Chinese (17) 17
Korean (3) 3
Portuguese (3) 3
Croatian (2) 2
Russian (2) 2
Spanish (2) 2
Danish (1) 1
Greek (1) 1
Hungarian (1) 1
Indonesian (1) 1
Italian (1) 1
Lithuanian (1) 1
Polish (1) 1
Serbian (1) 1
Slovenian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Broadly Neutralizing Anti-HIV-1 Antibodies Require Fc Effector Functions for In Vivo Activity
by Bournazos, Stylianos and Klein, Florian and Pietzsch, John and Seaman, Michael S and Nussenzweig, Michel C and Ravetch, Jeffrey V
Cell, ISSN 0092-8674, 09/2014, Volume 158, Issue 6, pp. 1243 - 1253
Broadly neutralizing antibodies (bNAbs) against HIV-1 provide both effective pre-exposure prophylaxis and treatment of HIV-1 infection in murine and nonhuman... 
POTENT | PROTECTION | BIOCHEMISTRY & MOLECULAR BIOLOGY | MOUSE MODEL | CD4 BINDING | MONOCLONAL-ANTIBODY | GAMMA-R | HIV-ANTIBODIES | MACAQUES | RECEPTOR-BINDING | HUMANIZED MICE | CELL BIOLOGY | HIV-1 | env Gene Products, Human Immunodeficiency Virus - immunology | Antibodies, Viral - therapeutic use | Humans | Receptors, IgG - metabolism | Animals | Immunoglobulin G - immunology | Antibodies, Neutralizing - therapeutic use | Primates | HIV Infections - drug therapy | Mice | Immunoglobulin Fc Fragments - genetics | Disease Models, Animal | Virus diseases | Viral antibodies | Medical research | Analysis | Medicine, Experimental | Antibodies | HIV (Viruses) | Molecular genetics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges
by Gardner, Matthew R and Kattenhorn, Lisa M and Kondur, Hema R and Von Schaewen, Markus and Dorfman, Tatyana and Chiang, Jessica J and Haworth, Kevin G and Decker, Julie M and Alpert, Michael D and Bailey, Charles C and Neale, Ernest S and Fellinger, Christoph H and Joshi, Vinita R and Fuchs, Sebastian P and Martinez-Navio, Jose M and Quinlan, Brian D and Yao, Annie Y and Mouquet, Hugo and Gorman, Jason and Zhang, Baoshan and Poignard, Pascal and Nussenzweig, Michel C and Burton, Dennis R and Kwong, Peter D and Piatak, Michael and Lifson, Jeffrey D and Gao, Guangping and Desrosiers, Ronald C and Evans, David T and Hahn, Beatrice H and Ploss, Alexander and Cannon, Paula M and Seaman, Michael S and Farzan, Michael
Nature, ISSN 0028-0836, 03/2015, Volume 519, Issue 7541, pp. 87 - 91
Long-term in vivo expression of a broad and potent entry inhibitor could circumvent the need for a conventional vaccine for HIV-1. Adeno-associated virus (AAV)... 
HIV-1 GP120 | NEUTRALIZING ANTIBODIES | POTENT NEUTRALIZATION | MULTIDISCIPLINARY SCIENCES | TYROSINE SULFATION | IMMUNODEFICIENCY-VIRUS TYPE-1 | FUSION INHIBITOR T-20 | ENVELOPE GLYCOPROTEIN | N-TERMINUS | MONOCLONAL-ANTIBODIES | PEPTIDE VARIANTS | Dependoviruses | Research | Genetic vectors | Gene expression | HIV (Viruses) | Analysis | Studies | Medical research | Immunoglobulins | Human immunodeficiency virus--HIV | Primates | Glycoproteins | Binding sites
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Scientific examination of questioned documents
by Kelly, Jan Seaman and Lindblom, Brian S
2006, 2nd ed., ISBN 0849320445, xviii, 441 p., [28] p. of plates
Writing | Forgery | Identification
Book
Details down arrow
4. Full Text Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection
by Hraber, Peter and Seaman, Michael S and Bailer, Robert T and Mascola, John R and Montefiori, David C and Korber, Bette T
AIDS, ISSN 0269-9370, 01/2014, Volume 28, Issue 2, pp. 163 - 169
Objective:Studies of neutralizing antibodies in HIV-1 infected individuals provide insights into the quality of the response that should be possible to elicit... 
HIV-1 | Serum | Vaccines | Neutralizing antibodies | Immunity | INFECTIOUS DISEASES | MUCOSAL SHIV CHALLENGE | PANEL | DOMAIN | PROTECTION | vaccines | neutralizing antibodies | immunity | IMMUNOLOGY | MAGNITUDE | EPITOPE | VIROLOGY | serum | MONOCLONAL-ANTIBODIES | BREADTH | HIV Antibodies - blood | HIV Infections - immunology | Neutralization Tests | HIV-1 - immunology | Humans | Antibodies, Neutralizing - blood
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Broadly Neutralizing HIV Antibodies Define a Glycan-Dependent Epitope on the Prefusion Conformation of gp41 on Cleaved Envelope Trimers
by Falkowska, Emilia and Le, Khoa M and Ramos, Alejandra and Doores, Katie J and Lee, Jeong Hyun and Blattner, Claudia and Ramirez, Alejandro and Derking, Ronald and van Gils, Marit J and Liang, Chi-Hui and Mcbride, Ryan and von Bredow, Benjamin and Shivatare, Sachin S and Wu, Chung-Yi and Chan-Hui, Po-Ying and Liu, Yan and Feizi, Ten and Zwick, Michael B and Koff, Wayne C and Seaman, Michael S and Swiderek, Kristine and Moore, John P and Evans, David and Paulson, James C and Wong, Chi-Huey and Ward, Andrew B and Wilson, Ian A and Sanders, Rogier W and Poignard, Pascal and Burton, Dennis R
Immunity, ISSN 1074-7613, 05/2014, Volume 40, Issue 5, pp. 657 - 668
Broadly neutralizing HIV antibodies are much sought after (a) to guide vaccine design, both as templates and as indicators of the authenticity of vaccine... 
DESIGN | POTENT NEUTRALIZATION | SITE-SPECIFIC ANALYSIS | RECOGNITION | CD4 BINDING-SITE | VACCINE | GLYCOPROTEIN | GP120 | IMMUNOLOGY | HUMAN MONOCLONAL-ANTIBODIES | COMBINATION | Cell Line | HIV Infections - prevention & control | HIV Envelope Protein gp41 - immunology | Humans | HIV Envelope Protein gp41 - metabolism | Molecular Sequence Data | Polysaccharides - immunology | Epitopes - immunology | HIV Envelope Protein gp120 - immunology | HIV Infections - immunology | Antibodies, Neutralizing - immunology | HIV-1 - immunology | HIV Antibodies - immunology | HEK293 Cells | Antibodies, Monoclonal - immunology | Monoclonal antibodies | AIDS vaccines | HIV antibodies | HIV (Viruses) | Antigenic determinants | Studies | Antigens | Medical research | Acquired immune deficiency syndrome--AIDS | Viruses | Vaccines | Grants | Binding sites
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials
by Modjarrad, Kayvon and Lin, Leyi and George, Sarah L and Stephenson, Kathryn E and Eckels, Kenneth H and De La Barrera, Rafael A and Jarman, Richard G and Sondergaard, Erica and Tennant, Janice and Ansel, Jessica L and Mills, Kristin and Koren, Michael and Robb, Merlin L and Barrett, Jill and Thompson, Jason and Kosel, Alison E and Dawson, Peter and Hale, Andrew and Tan, C Sabrina and Walsh, Stephen R and Walsh, Melissa and Meyer, Keith E and Brien, James and Crowell, Trevor A and Blazevic, Azra and Mosby, Karla and Larocca, Rafael A and Abbink, Peter and Boyd, Michael and Bricault, Christine A and Seaman, Michael S and Basil, Anne and Tonwe, Veronica and Hoft, Daniel F and Thomas, Stephen J and Barouch, Dan H and Michael, Nelson L
The Lancet, ISSN 0140-6736, 02/2018, Volume 391, Issue 10120, pp. 563 - 571
A safe, effective, and rapidly scalable vaccine against Zika virus infection is needed. We developed a purified formalin-inactivated Zika virus vaccine (ZPIV)... 
MEDICINE, GENERAL & INTERNAL | INFECTION | PROTECTIVE EFFICACY | GUILLAIN-BARRE-SYNDROME | PREGNANCY | Antibodies, Viral - biosynthesis | Zika Virus - immunology | Double-Blind Method | Antibodies, Neutralizing - biosynthesis | Humans | Antibodies, Viral - blood | Viral Vaccines - immunology | Antibodies, Neutralizing - blood | Viral Vaccines - administration & dosage | Vector-borne diseases | Medical research | Encephalitis | Congenital diseases | Research & development--R&D | Hypersensitivity | Clinical trials | Viruses | Zika virus | Vaccines | Epidemiology | Studies | Infectious diseases | Immunogenicity | Drug dosages | Deoxyribonucleic acid--DNA | Viral infections
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys
by Barouch, Dan H and Liu, Jinyan and Li, Hualin and Maxfield, Lori F and Abbink, Peter and Lynch, Diana M and Iampietro, M. Justin and Sanmiguel, Adam and Seaman, Michael S and Ferrari, Guido and Forthal, Donald N and Ourmanov, Ilnour and Hirsch, Vanessa M and Carville, Angela and Mansfield, Keith G and Stablein, Donald and Pau, Maria G and Schuitemaker, Hanneke and Sadoff, Jerald C and Billings, Erik A and Rao, Mangala and Robb, Merlin L and Kim, Jerome H and Marovich, Mary A and Goudsmit, Jaap and Michael, Nelson L
Nature, ISSN 0028-0836, 2012, Volume 482, Issue 7383, pp. 89 - 93
Preclinical studies of human immunodeficiency virus type 1 (HIV-1) vaccine candidates have typically shown post-infection virological control, but protection... 
ANTIBODIES | MEMORY | MULTIDISCIPLINARY SCIENCES | CELLULAR IMMUNE-RESPONSES | INFECTION | MACAQUES | LOW-DOSE CHALLENGE | VECTORS | BREADTH | Enzyme-Linked Immunosorbent Assay | AIDS Vaccines - immunology | Macaca mulatta - immunology | Male | Neutralization Tests | Antibodies, Neutralizing - immunology | HIV-1 - immunology | Animals | SAIDS Vaccines - immunology | Adenoviridae - genetics | Female | Adenoviridae - immunology | Viral Vaccines - immunology | Simian Immunodeficiency Virus - immunology | Prevention | Rhesus monkey | AIDS vaccines | Product development | Simian immunodeficiency virus | Diseases | Confidence intervals | Cytotoxicity | Immunization | Vaccines | Adenoviruses | Deoxyribonucleic acid--DNA
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies
by Mouquet, Hugo and Scharf, Louise and Euler, Zelda and Liu, Yan and Eden, Caroline and Scheid, Johannes F and Halper-Stromberg, Ariel and Gnanapragasam, Priyanthi N. P and Spencer, Daniel I. R and Seaman, Michael S and Schuitemaker, Hanneke and Feizi, Ten and Nussenzweig, Michel C and Bjorkman, Pamela J
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 2012, Volume 109, Issue 47, pp. E3268 - E3277
Broadly neutralizing HIV antibodies (bNAbs) can recognize carbohydrate-dependent epitopes on gp120. In contrast to previously characterized glycan-dependent... 
B-CELL RESPONSES | SIMIAN/HUMAN IMMUNODEFICIENCY VIRUS | HIV-1/SIV CHIMERIC VIRUS | SITE-SPECIFIC ANALYSIS | MULTIDISCIPLINARY SCIENCES | ENVELOPE GLYCOPROTEIN | HUMORAL IMMUNITY | HIV-1-INFECTED INDIVIDUALS | HUMAN MONOCLONAL-ANTIBODIES | MASS-SPECTROMETRY | GLYCOSYLATION SITES | Amino Acid Sequence | Humans | Models, Molecular | Molecular Sequence Data | Crystallography, X-Ray | Mutant Proteins - metabolism | Neutralization Tests | Polysaccharides - immunology | HIV Antibodies - chemistry | Epitopes - immunology | Antibodies, Neutralizing - immunology | HIV-1 - immunology | HIV Antibodies - immunology | Antibodies, Neutralizing - chemistry | Immunoglobulin Fab Fragments - chemistry | Leukocytes, Mononuclear - immunology | Polysaccharides - chemistry | Protein Binding | Ligands | Clone Cells | Immunoglobulin Fab Fragments - immunology | Amino Acid Substitution | Proteins | Molecules | Carbohydrates | Molecular structure | Human immunodeficiency virus--HIV | Cloning | Binding sites | PNAS Plus | Biological Sciences
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Broadly Neutralizing Antibodies and Viral Inducers Decrease Rebound from HIV-1 Latent Reservoirs in Humanized Mice
by Halper-Stromberg, Ariel and Lu, Ching-Lan and Klein, Florian and Horwitz, Joshua A and Bournazos, Stylianos and Nogueira, Lilian and Eisenreich, Thomas R and Liu, Cassie and Gazumyan, Anna and Schaefer, Uwe and Furze, Rebecca C and Seaman, Michael S and Prinjha, Rab and Tarakhovsky, Alexander and Ravetch, Jeffrey V and Nussenzweig, Michel C
Cell, ISSN 0092-8674, 08/2014, Volume 158, Issue 5, pp. 989 - 999
Latent reservoirs of HIV-1-infected cells are refractory to antiretroviral therapies (ART) and remain the major barrier to curing HIV-1. Because latently... 
INFECTED RHESUS-MONKEYS | VIREMIA | IMMUNE-RESPONSES | BIOCHEMISTRY & MOLECULAR BIOLOGY | ACTIVE ANTIRETROVIRAL THERAPY | SYNERGISTIC ACTIVATION | IN-VIVO | TO-CELL SPREAD | MACAQUES | MONOCLONAL-ANTIBODIES | CYTOTOXICITY | CELL BIOLOGY | Heterocyclic Compounds, 4 or More Rings - administration & dosage | Antibodies, Neutralizing - administration & dosage | Transcription, Genetic - drug effects | HIV-1 - drug effects | HIV Infections - virology | Humans | HIV-1 - genetics | Virus Latency - drug effects | CD4-Positive T-Lymphocytes - immunology | HIV Infections - immunology | Antibodies, Neutralizing - immunology | CTLA-4 Antigen - administration & dosage | Animals | HIV-1 - physiology | Immunoglobulin Fc Fragments - immunology | Receptors, Fc - immunology | Hydroxamic Acids - administration & dosage | Anti-HIV Agents - therapeutic use | Mice | Viral antibodies | Antibodies | Highly active antiretroviral therapy | Antiviral agents | Fc receptors | HIV (Viruses) | Virus diseases | Molecular genetics | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Natively glycosylated HIV-1 Env structure reveals new mode for antibody recognition of the CD4-binding site
by Gristick, Harry B and Von Boehmer, Lotta and West, Anthony P and Schamber, Michael and Gazumyan, Anna and Golijanin, Jovana and Seaman, Michael S and Fätkenheuer, Gerd and Klein, Florian and Nussenzweig, Michel C and Bjorkman, Pamela J
Nature Structural and Molecular Biology, ISSN 1545-9993, 10/2016, Volume 23, Issue 10, pp. 906 - 915
HIV-1 vaccine design is informed by structural studies elucidating mechanisms by which broadly neutralizing antibodies (bNAbs) recognize and/or accommodate... 
GERMLINE | COMPLEX | CRYSTAL-STRUCTURE | BIOCHEMISTRY & MOLECULAR BIOLOGY | ENVELOPE GLYCOPROTEIN | CELL BIOLOGY | MATURATION PATHWAY | B-CELLS | POTENT | BIOPHYSICS | BROADLY NEUTRALIZING ANTIBODIES | 8ANC195 | N-GLYCAN RECOGNITION | CD4 Antigens - immunology | Epitopes - analysis | Mannose - immunology | HIV Infections - virology | Humans | Protein Multimerization | Models, Molecular | Crystallography, X-Ray | Glycosylation | Polysaccharides - immunology | HIV Antibodies - chemistry | Polysaccharides - analysis | Mannose - analysis | Epitopes - immunology | HIV Envelope Protein gp120 - immunology | HIV Infections - immunology | Antibodies, Neutralizing - immunology | HIV-1 - immunology | HIV Antibodies - immunology | CD4 Antigens - chemistry | HIV-1 - chemistry | Antibodies, Neutralizing - chemistry | Protein Conformation | HIV Envelope Protein gp120 - chemistry | Viral antibodies | CD4 lymphocytes | Analysis | Antibodies | Research | Chemical properties | HIV (Viruses) | Immunoglobulins | Vaccines | Human immunodeficiency virus--HIV | Binding sites | Crystal structure
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights